Aldeyra Therapeutics (ALDX) Stock Chart & Stock Price History $5.01 +0.36 (+7.74%) Closing price 04:00 PM EasternExtended Trading$5.04 +0.03 (+0.60%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Aldeyra Therapeutics Stock Price Performance The Aldeyra Therapeutics (ALDX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 29.79%, with a year-to-date return of 0.40%. In the past month, the stock has increased 80.22%, reflecting recent market activity. As of the latest close, Aldeyra Therapeutics traded at $4.65 with a market cap of $278.52 million and volume of 1.38 million shares. Five years ago, the stock traded at $5.70, representing a 12.11% decrease over that period. At the time, it had a market cap of $143.59 million and a volume of 4.69 million shares. Receive ALDX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aldeyra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+10.84%1 Month Performance+80.22%3 Month Performance+136.32%Year-To-Date Performance+0.40%1 Year Performance+29.79%5 Year Performance-12.11% ALDX Stock Chart for Monday, July, 14, 2025 ALDX Chart by TradingView Aldeyra Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$4.80$4.65-3.12%$4.81$4.551.38 million shs$278.52 million07/10/2025$4.52$4.80+6.19%$4.92$4.441.41 million shs$287.52 million07/09/2025$4.33$4.52+4.39%$4.60$4.341.74 million shs$270.75 million07/08/2025$4.35$4.33-0.46%$4.44$4.121.10 million shs$259.35 million07/07/2025$4.31$4.35+1.05%$4.43$4.16906,880 shs$260.57 million07/04/2025$4.31$4.31$4.34$4.00757,113 shs$257.85 million07/03/2025$4.00$4.31+7.62%$4.34$4.00757,113 shs$257.87 million07/02/2025$3.93$4.00+1.78%$4.21$3.941.50 million shs$239.60 million07/01/2025$3.83$3.93+2.61%$4.04$3.73922,837 shs$235.41 million06/30/2025$3.79$3.83+1.06%$3.98$3.681.51 million shs$229.42 million Get the Latest News and Ratings for ALDX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aldeyra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$3.87$3.79-2.07%$4.00$3.742.54 million shs$227.02 million06/26/2025$3.51$3.87+10.26%$3.93$3.521.96 million shs$231.80 million06/25/2025$3.35$3.51+4.78%$3.64$3.291.25 million shs$210.25 million06/24/2025$3.09$3.35+8.41%$3.37$3.00684,564 shs$200.67 million06/23/2025$3.05$3.09+1.31%$3.16$2.95584,667 shs$185.09 million06/20/2025$3.17$3.05-3.79%$3.29$3.01801,493 shs$182.70 million06/19/2025$3.17$3.17$3.20$3.01688,142 shs$189.88 million06/18/2025$3.09$3.17+2.59%$3.20$3.01688,142 shs$189.88 million06/17/2025$3.02$3.09+2.32%$3.24$2.97929,892 shs$185.08 million06/16/2025$2.78$3.02+8.63%$3.04$2.601.16 million shs$180.89 million06/13/2025$2.93$2.78-5.12%$2.95$2.751.18 million shs$166.51 million Related Companies AUPH Stock Chart ARDX Stock Chart ELVN Stock Chart VERV Stock Chart NAGE Stock Chart DYN Stock Chart CDTX Stock Chart COLL Stock Chart BGM Stock Chart PHVS Stock Chart Receive ALDX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aldeyra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALDX) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredAn extra $1,000 per month?A little-known Title 15 provision could let you collect instant payouts — $100 to $1,000 — directly from your ...TradeSmith | SponsoredBanks aren’t ready for this altcoin—are you?An investment opportunity you CAN’T miss… This isn't just any crypto coin- It's a groundbreaking opportunit...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aldeyra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aldeyra Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.